

Cover Story
Ivan Borrello, medical director of the Myeloma, Bone Marrow Transplant and Cell Therapies Program at Tampa General Hospital’s Cancer Institute, watched as flood waters from Hurricane Helene heaved against a contraption called the AquaFence, which is, as the name suggests, a water-impermeable barrier made of marine-grade laminate and various metals that can withstand storm surges of up to 15 feet above sea level.
In Brief


Drugs & Targets


Trending Stories
- Brawley: ACS prostate cancer screening guideline should say no to “mass screening”
- NCI’s Letai, FDA’s Diamantas identify strategies to speed up cancer trials
Letai: 150 days to start a cancer trial is too long—cancer centers need to accept a little risk - USPSTF convenes first meeting in over a year
- Cancer Grand Challenges awards $10M to research team aiming to develop AI “co-scientists”
AI agents would narrow the “incredibly large combinatorial universe of cancer questions” - Philadelphia cancer center directors talk city-wide collaboration
“A bench-to-bedside-to-block model” - The next revolution in cancer care may be manufactured at the bedside
As personalized mRNA cancer vaccines move toward clinical reality, the challenge will be to make them broadly available
















